SCHEMBL27434685

SCHEMBL27434685

C=C1CCC(n2cc(C)nn2)C(=O)N1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 2/20 0.37
▸ PSEN2 P49810 2/20 0.37
▸ KCNH2 Q12809 2/20 0.37
▸ APH1B Q8WW43 2/20 0.37
▸ NCSTN Q92542 2/20 0.37
▸ APH1A Q96BI3 2/20 0.37
▸ PSENEN Q9NZ42 2/20 0.37
▸ DDB1 Q16531 11/20 0.36
▸ CRBN Q96SW2 11/20 0.36
▸ SRC P12931 4/20 0.36
▸ IKZF3 Q9UKT9 2/20 0.32
▸ KDM5A P29375 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31
▸ CHRM2 P08172 1/20 0.31
▸ OPRM1 P35372 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ TSHR P16473 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27411925 0.87 SRC (0.33) DDB1CRBNSRCKDM5A
SCHEMBL27434692 0.85 CRBN (0.47) DDB1CRBNIKZF3ALDH1A1CHRM2
SCHEMBL19709588 0.72 PSEN1 (0.36) PSEN1PSEN2KCNH2APH1BNCSTN
SCHEMBL22511869 0.69 CRBN (0.35) DDB1CRBNIKZF3ALDH1A1CHRM2
SCHEMBL23798041 0.69 CRBN (0.42) DDB1CRBNIKZF3ALDH1A1CHRM2
SCHEMBL25091816 0.68 CRBN (0.44) DDB1CRBNIKZF3ALDH1A1CHRM2
SCHEMBL22711433 0.66 CRBN (0.42) PSEN1PSEN2KCNH2APH1BNCSTN
SCHEMBL20436926 0.66 DDB1 (0.35) DDB1CRBN
SCHEMBL20812705 0.65 CRBN (0.54) PSEN1PSEN2KCNH2APH1BNCSTN
SCHEMBL26158796 0.65 CRBN (0.45) DDB1CRBNIKZF3ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112119-A1 DEGRADER FOR DECOMPOSING CMET PROTEIN, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 이노큐어테라퓨틱스 2024-05-30 — — WO disclosed
Send feedback